{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T20:49:04Z","timestamp":1765486144345,"version":"3.48.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T00:00:00Z","timestamp":1758672000000},"content-version":"vor","delay-in-days":266,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006662","name":"Ardabil University of Medical Sciences","doi-asserted-by":"publisher","award":["403000220"],"award-info":[{"award-number":["403000220"]}],"id":[{"id":"10.13039\/501100006662","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Treatment and Research Communications"],"published-print":{"date-parts":[[2025]]},"DOI":"10.1016\/j.ctarc.2025.101007","type":"journal-article","created":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T19:44:45Z","timestamp":1758829485000},"page":"101007","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Photodynamic therapy with zinc phthalocyanine enhances cisplatin sensitivity of human muscle-invasive bladder cancer cells by downregulation of PI3K\/AKT\/mTOR signaling pathway"],"prefix":"10.1016","volume":"45","author":[{"given":"Fateme","family":"Mohammadnejad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neda","family":"Rajabi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Amin","family":"Doustvandi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shima Alizadeh","family":"Nobari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masoumeh","family":"Hosseinpour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadia Allahyarzadeh","family":"Khiabani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Amini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Behzad","family":"Baradaran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leili Aghebati","family":"Maleki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2020","series-title":"International Agency for Research on Cancer GLOBOCAN 2020","author":"Organization","key":"10.1016\/j.ctarc.2025.101007_bib0001"},{"key":"10.1016\/j.ctarc.2025.101007_bib0002","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2023.102530","article-title":"Role of FGFR3 in bladder cancer: treatment landscape and future challenges","volume":"115","author":"Ascione","year":"2023","journal-title":"Cancer Treat. Rev."},{"issue":"4","key":"10.1016\/j.ctarc.2025.101007_bib0003","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.euo.2023.02.011","article-title":"Cancer-associated fibroblasts in bladder cancer: origin, biology, and therapeutic opportunities","volume":"6","author":"Caramelo","year":"2023","journal-title":"Eur. Urol. Oncol."},{"issue":"2","key":"10.1016\/j.ctarc.2025.101007_bib0004","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.eururo.2012.07.033","article-title":"Epidemiology and risk factors of urothelial bladder cancer","volume":"63","author":"Burger","year":"2013","journal-title":"Eur. Urol."},{"issue":"1","key":"10.1016\/j.ctarc.2025.101007_bib0005","first-page":"7","article-title":"Cancer statistics, 2019","volume":"69","author":"Siegel","year":"2019","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.ctarc.2025.101007_bib0006","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1007\/s00345-018-2544-8","article-title":"Forty years of cisplatin-based chemotherapy in muscle-invasive bladder cancer: are we understanding how, who and when?","volume":"37","author":"Schardt","year":"2019","journal-title":"World J. Urol."},{"issue":"17","key":"10.1016\/j.ctarc.2025.101007_bib0007","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1200\/JCO.2011.34.8433","article-title":"Treatment of patients with metastatic urothelial cancer \u201cunfit\u201d for cisplatin-based chemotherapy","volume":"29","author":"Galsky","year":"2011","journal-title":"J. Clin. Oncol."},{"issue":"21","key":"10.1016\/j.ctarc.2025.101007_bib0008","doi-asserted-by":"crossref","first-page":"4602","DOI":"10.1200\/JCO.2005.07.757","article-title":"Long-term survival results of a randomized trial comparing gemcitabine plus cisplatin, with methotrexate, vinblastine, doxorubicin, plus cisplatin in patients with bladder cancer","volume":"23","author":"von der Maase","year":"2005","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.ctarc.2025.101007_bib0009","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.mrgentox.2012.03.004","article-title":"Cisplatin treatment leads to changes in nuclear protein and microRNA expression","volume":"746","author":"Zhang","year":"2012","journal-title":"Mutat. Res.\/Genet. Toxicol. Environ. Mutagen."},{"key":"10.1016\/j.ctarc.2025.101007_bib0010","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.539527","article-title":"Novel combination therapies for the treatment of bladder cancer","volume":"10","author":"Peng","year":"2021","journal-title":"Front. Oncol."},{"issue":"2","key":"10.1016\/j.ctarc.2025.101007_bib0011","first-page":"149","article-title":"A review of chemotherapy and photodynamic therapy for lung cancer treatment","volume":"21","author":"El-Hussein","year":"2021","journal-title":"Anti-cancer Agents Med. Chem. (Former. Curr. Med. Chem.-Anti-Cancer Agents)"},{"issue":"3","key":"10.1016\/j.ctarc.2025.101007_bib0012","doi-asserted-by":"crossref","first-page":"731","DOI":"10.3390\/molecules27030731","article-title":"Advances in management of bladder cancer\u2014The role of photodynamic therapy","volume":"27","author":"Kubrak","year":"2022","journal-title":"Molecules"},{"issue":"8","key":"10.1016\/j.ctarc.2025.101007_bib0013","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1039\/c4pp00495g","article-title":"The role of photodynamic therapy in overcoming cancer drug resistance","volume":"14","author":"Spring","year":"2015","journal-title":"Photochem. Photobiol. Sci."},{"issue":"3","key":"10.1016\/j.ctarc.2025.101007_bib0014","first-page":"561","article-title":"Photodynamic combinational therapy in cancer treatment","volume":"23","author":"Zhang","year":"2018","journal-title":"J. Buon"},{"issue":"17","key":"10.1016\/j.ctarc.2025.101007_bib0015","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.2174\/092986708784872401","article-title":"Combination of photodynamic therapy with anti-cancer agents","volume":"15","author":"Zuluaga","year":"2008","journal-title":"Curr. Med. Chem"},{"issue":"1","key":"10.1016\/j.ctarc.2025.101007_bib0016","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s40005-024-00698-3","article-title":"Emerging trends in quantum dot-based photosensitizers for enhanced photodynamic therapy in cancer treatment","volume":"55","author":"Alizadeh Nobari","year":"2025","journal-title":"J. Pharm. Investig."},{"issue":"22","key":"10.1016\/j.ctarc.2025.101007_bib0017","doi-asserted-by":"crossref","first-page":"6877","DOI":"10.3390\/molecules26226877","article-title":"Photodynamic therapy with zinc phthalocyanine inhibits the stemness and development of colorectal cancer: time to overcome the challenging barriers?","volume":"26","author":"Gholizadeh","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.ctarc.2025.101007_bib0018","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1007\/s12094-008-0172-2","article-title":"Photodynamic therapy of cancer. Basic principles and applications","volume":"10","author":"Juarranz","year":"2008","journal-title":"Clin. Transl. Oncol."},{"key":"10.1016\/j.ctarc.2025.101007_bib0019","doi-asserted-by":"crossref","DOI":"10.1016\/j.pdpdt.2020.101893","article-title":"Mitomycin C-induced cell cycle arrest enhances 5-aminolevulinic acid-based photodynamic therapy for bladder cancer","volume":"31","author":"Nakayama","year":"2020","journal-title":"Photodiagnosis Photodyn. Ther."},{"issue":"4","key":"10.1016\/j.ctarc.2025.101007_bib0020","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.euf.2018.08.005","article-title":"Photodynamic therapy in the treatment of bladder cancer: past challenges and current innovations","volume":"4","author":"Railkar","year":"2018","journal-title":"Eur. Urol. Focus"},{"key":"10.1016\/j.ctarc.2025.101007_bib0021","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.121061","article-title":"Enhanced chemo-photodynamic therapy of an enzyme-responsive prodrug in bladder cancer patient-derived xenograft models","volume":"277","author":"Tan","year":"2021","journal-title":"Biomaterials"},{"key":"10.1016\/j.ctarc.2025.101007_bib0022","doi-asserted-by":"crossref","first-page":"S60","DOI":"10.1002\/pros.24372","article-title":"PTEN-PI3K pathway alterations in advanced prostate cancer and clinical implications","volume":"82","author":"Choudhury","year":"2022","journal-title":"Prostate"},{"key":"10.1016\/j.ctarc.2025.101007_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2022.103749","article-title":"Prospects of targeting PI3K\/AKT\/mTOR pathway in pancreatic cancer","volume":"176","author":"Mortazavi","year":"2022","journal-title":"Crit. Rev. Oncol. Hematol"},{"key":"10.1016\/j.ctarc.2025.101007_bib0024","article-title":"Crosstalk between PI3K\/AKT\/mTOR and WNT\/\u03b2-catenin signaling in GBM-could combination therapy checkmate the collusion?","volume":"95","author":"Precilla","year":"2022","journal-title":"Cell. Signal"},{"issue":"5","key":"10.1016\/j.ctarc.2025.101007_bib0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00394-020-02440-9","article-title":"6-Shogaol from ginger shows anti-tumor effect in cervical carcinoma via PI3K\/akt\/mTOR pathway","volume":"60","author":"Pei","year":"2021","journal-title":"Eur. J. Nutr."},{"key":"10.1016\/j.ctarc.2025.101007_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2023.175909","article-title":"PI3K\/akt signaling in urological cancers: tumorigenesis function, therapeutic potential, and therapy response regulation","volume":"955","author":"Rezaei","year":"2023","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.ctarc.2025.101007_bib0027","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-06965-z","article-title":"mTOR pathway targeted inhibition via Rapamycin-loaded PLGA nanoparticles for enhanced bladder cancer therapy","volume":"15","author":"El-Hefnawy","year":"2025","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.ctarc.2025.101007_bib0028","doi-asserted-by":"crossref","DOI":"10.1002\/aoc.70224","article-title":"Targeting the PI3K\/AKT\/mTOR signaling pathway in TCCSUP bladder cancer cell by the Panax ginseng leaf extract green-synthesized silver nanoparticles","volume":"39","author":"Mu","year":"2025","journal-title":"Appl. Organomet Chem."},{"key":"10.1016\/j.ctarc.2025.101007_bib0029","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jphotobiol.2017.09.020","article-title":"The interaction between the light source dose and caspase-dependent and-independent apoptosis in human SK-MEL-3 skin cancer cells following photodynamic therapy with zinc phthalocyanine: a comparative study","volume":"176","author":"Doustvandi","year":"2017","journal-title":"J. Photochem. Photobiol. B: Biol."},{"key":"10.1016\/j.ctarc.2025.101007_bib0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2022.110553","article-title":"DHCR7 promotes tumorigenesis via activating PI3K\/AKT\/mTOR signalling pathway in bladder cancer","volume":"102","author":"Li","year":"2023","journal-title":"Cell. Signal."},{"issue":"1","key":"10.1016\/j.ctarc.2025.101007_bib0031","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s12943-022-01517-9","article-title":"Targeting HNRNPU to overcome cisplatin resistance in bladder cancer","volume":"21","author":"Shi","year":"2022","journal-title":"Mol. Cancer"},{"issue":"13","key":"10.1016\/j.ctarc.2025.101007_bib0032","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.7150\/ijbs.27854","article-title":"PKM2 inhibitor shikonin overcomes the cisplatin resistance in bladder cancer by inducing necroptosis","volume":"14","author":"Wang","year":"2018","journal-title":"Int. J. Biol. Sci."},{"year":"2019","series-title":"PI3K\/Akt\/mTOR Inhibitors in cancer: At the Bench and bedside. in Seminars in Cancer Biology","author":"Alzahrani","key":"10.1016\/j.ctarc.2025.101007_bib0033"},{"issue":"10","key":"10.1016\/j.ctarc.2025.101007_bib0034","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.15001","article-title":"Derlin-1 overexpression confers poor prognosis in muscle invasive bladder cancer and contributes to chemoresistance and invasion through PI3K\/AKT and ERK\/MMP signaling","volume":"8","author":"Dong","year":"2017","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.ctarc.2025.101007_bib0035","first-page":"1","article-title":"Berberine enhances gemcitabine\u2011induced cytotoxicity in bladder cancer by downregulating Rad51 expression through inactivating the PI3K\/Akt pathway","volume":"47","author":"Gao","year":"2022","journal-title":"Oncol. Rep."},{"issue":"3","key":"10.1016\/j.ctarc.2025.101007_bib0036","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/jcmm.12760","article-title":"miR-222 attenuates cisplatin-induced cell death by targeting the PPP 2R2A\/akt\/mTOR axis in bladder cancer cells","volume":"20","author":"Zeng","year":"2016","journal-title":"J. Cell. Mol. Med"},{"issue":"19","key":"10.1016\/j.ctarc.2025.101007_bib0037","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1038\/sj.gt.3302056","article-title":"In vivo gene therapy of human bladder cancer with PTEN suppresses tumor growth, downregulates phosphorylated Akt, and increases sensitivity to doxorubicin","volume":"10","author":"Tanaka","year":"2003","journal-title":"Gene. Ther."},{"issue":"5","key":"10.1016\/j.ctarc.2025.101007_bib0038","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1159\/000052494","article-title":"Bladder cancer: I. Molecular and genetic basis of carcinogenesis","volume":"39","author":"Brandau","year":"2001","journal-title":"Eur. Urol"},{"key":"10.1016\/j.ctarc.2025.101007_bib0039","doi-asserted-by":"crossref","DOI":"10.1016\/j.pdpdt.2022.103212","article-title":"Photodynamic therapy with zinc phthalocyanine enhances the anti-cancer effect of tamoxifen in breast cancer cell line: promising combination treatment against triple-negative breast cancer?","volume":"41","author":"Rajabi","year":"2023","journal-title":"Photodiagnosis Photodyn. Ther."},{"issue":"9","key":"10.1016\/j.ctarc.2025.101007_bib0040","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1038\/s41388-020-01634-z","article-title":"KNSTRN promotes tumorigenesis and gemcitabine resistance by activating AKT in bladder cancer","volume":"40","author":"Xiong","year":"2021","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.ctarc.2025.101007_bib0041","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1186\/s13046-022-02377-3","article-title":"TEAD4 functions as a prognostic biomarker and triggers EMT via PI3K\/AKT pathway in bladder cancer","volume":"41","author":"Chi","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"2","key":"10.1016\/j.ctarc.2025.101007_bib0042","doi-asserted-by":"crossref","first-page":"690","DOI":"10.3892\/ijo.2015.3041","article-title":"CXCL5\/CXCR2 axis promotes bladder cancer cell migration and invasion by activating PI3K\/AKT-induced upregulation of MMP2\/MMP9","volume":"47","author":"Gao","year":"2015","journal-title":"Int. J. Oncol"},{"issue":"5","key":"10.1016\/j.ctarc.2025.101007_bib0043","doi-asserted-by":"crossref","first-page":"7535","DOI":"10.1021\/acsnano.1c10770","article-title":"Photo-enhanced chemotherapy performance in bladder cancer treatment via albumin coated AIE aggregates","volume":"16","author":"Ding","year":"2022","journal-title":"ACS Nano"}],"container-title":["Cancer Treatment and Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294225001431?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294225001431?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T20:40:27Z","timestamp":1765485627000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468294225001431"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":43,"alternative-id":["S2468294225001431"],"URL":"https:\/\/doi.org\/10.1016\/j.ctarc.2025.101007","relation":{},"ISSN":["2468-2942"],"issn-type":[{"type":"print","value":"2468-2942"}],"subject":[],"published":{"date-parts":[[2025]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Photodynamic therapy with zinc phthalocyanine enhances cisplatin sensitivity of human muscle-invasive bladder cancer cells by downregulation of PI3K\/AKT\/mTOR signaling pathway","name":"articletitle","label":"Article Title"},{"value":"Cancer Treatment and Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctarc.2025.101007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101007"}}